Surrozen (SRZN)

• Market cap: $113M
• 1 day: -3.93%
• 5 days: 5.1%
• 1 month: -4.69%
• 3 months: 16.3%
• 6 months: 80.57%
• Year to date: -7.37%
• 1 year: 41.94%
• 5 years: -91.3%
• 10 years: -91.3%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Employees: 41